DEXAMETHASONE TABLE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of five blister packs of Dexamethasone Tablets (NSN 6505-01-252-5602) at a unit price of $62.79, resulting in a total contract value of $313.95. The order, issued on July 14, 2026, with a required delivery date of July 29, 2026, is FOB Destination, meaning the contractor assumes all shipping responsibilities and risks until delivery to the specified location at Fort Bragg, North Carolina, with inspection and acceptance conducted by the government upon receipt. The awardee is certified as a small business, small disadvantaged business, and women-owned small business, triggering applicable socioeconomic reporting obligations under FAR provisions. Packaging and marking requirements mandate that all shipments be sent via the fastest traceable means—explicitly prohibiting parcel post—and must be clearly labeled with destination details, including facility code, building, and street address, using block printing. No formal MIL-STD, preservation, or barcoding standards are specified, though compliance with DLA’s unit of issue guidelines is expected. Payment is processed through the Defense Finance and Accounting Service in Columbus, Ohio, using voucher-based systems, and the contracting officer is Lisa Quinn, with administrative support provided by Shairy M. Cartagena. No individual contract clauses were identified in the document, and no attachments, evaluation factors, or special requirements beyond delivery, labeling, and socioeconomic certifications were included, indicating this is a direct, low-value, LPTA-style order governed primarily by the base IDIQ contract terms, with substitution permitted under rank 01.